NDC 72303-0844-01 - Olanzapine
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 72303-0844
- Requested NDC
- 72303-0844-01
- Package NDCs from labels
- 72303-0844-1, 72303-0844-01
- Manufacturer
- HEC Pharm USA Inc. | Sunshine Lake Pharma Co., Ltd.
- Effective date
- 2026-03-16
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Olanzapine - HEC Pharm USA Inc. | Sunshine Lake Pharma Co., Ltd. | HEC Pharm USA Inc. | Sunshine Lake Pharma Co., Ltd. | 2026-03-16 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 72303-0844-1 | Olanzapine | 30 in 1 BOTTLE, PLASTIC | TABLET, ORALLY DISINTEGRATING | 30 | 1 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Olanzapine | OLANZAPINE | REMEDYREPACK INC. | 76a6ff21-7157-4213-8073-35837a3ac07e | 2026-03-26 | Boxed warning, Warnings, Adverse reactions | N7U69T4SZR |
| Olanzapine Intramuscular | OLANZAPINE | UBI Pharma Inc. | 6a279fe1-ed99-4a62-b2c7-831961470fa9 | 2026-03-23 | Boxed warning, Warnings, Adverse reactions | N7U69T4SZR |
| Olanzapine | OLANZAPINE | HEC Pharm USA Inc. | 4d1b83db-54db-d51f-e063-6394a90a4a69 | 2026-03-16 | Boxed warning, Warnings, Adverse reactions | ANDA208146 72303-0842-1 72303-0841-1 72303-0844-1 72303-0843-1 72303-0841 72303-0844 72303-0843 72303-0842 72303084401 312076 351108 351107 314155 4d1b8476-a9ab-067a-e063-6294a90a57c0 4d1b83db-54db-d51f-e063-6394a90a4a69 N7U69T4SZR |
| OLANZAPINE | OLANZAPINE | HEC Pharm USA Inc. | 4d34f8f3-edc8-0a68-e063-6394a90a9c1f | 2026-03-16 | Boxed warning, Warnings, Adverse reactions | N7U69T4SZR |
| Olanzapine | OLANZAPINE | Dr.Reddy's Laboratories Limited | aff02cff-d079-bc82-6182-a24c4c6e09a6 | 2026-03-09 | Boxed warning, Warnings, Adverse reactions | 312076 351108 351107 314155 N7U69T4SZR |
| Olanzapine | OLANZAPINE | Dr. Reddy's Laboratories Inc. | d474d5a9-d338-511d-5823-567c0a1bbf4d | 2026-03-09 | Boxed warning, Warnings, Adverse reactions | N7U69T4SZR |
| OLANZAPINE | OLANZAPINE | Anthea Pharma Private Limited | e6ffcc56-63f9-4b12-a07a-c6177ffef5e8 | 2026-03-06 | Boxed warning, Warnings, Adverse reactions | N7U69T4SZR |
| Olanzapine | OLANZAPINE | Macleods Pharmaceuticals Limited | 8e095987-bdea-42f2-9550-c7155cf07d30 | 2026-03-05 | Boxed warning, Warnings, Adverse reactions | N7U69T4SZR |
| Olanzapine | OLANZAPINE | Macleods Pharmaceuticals Limited | df43938a-3469-40eb-8166-f0a2fd29d6d8 | 2026-03-05 | Boxed warning, Warnings, Adverse reactions | 312076 351108 351107 314155 N7U69T4SZR |
| OLANZAPINE | OLANZAPINE | Torrent Pharmaceuticals Limited | 2cb1bebe-0ced-46d8-bf21-c28a9acc4a15 | 2026-03-02 | Boxed warning, Warnings, Adverse reactions | 312076 351108 351107 314155 N7U69T4SZR |
| Olanzapine | OLANZAPINE | American Regent, Inc. | e9ac2bd3-dbff-4b1a-952f-da3909c6e4ee | 2026-03-01 | Boxed warning, Warnings, Adverse reactions | N7U69T4SZR |
| Olanzapine | OLANZAPINE | Teva Pharmaceuticals USA, Inc. | dd0b2525-4e2f-44fc-9302-0ae4ebb1e135 | 2026-02-27 | Boxed warning, Warnings, Adverse reactions | 312076 351108 351107 314155 N7U69T4SZR |
| Olanzapine | OLANZAPINE | Sandoz Inc | c44a96cc-817d-4eb5-a13a-00977f76e666 | 2026-02-26 | Boxed warning, Warnings, Adverse reactions | N7U69T4SZR |
| Olanzapine | OLANZAPINE | American Health Packaging | c0d705bf-b719-4c7b-b83d-c17d41cbbfad | 2026-02-20 | Boxed warning, Warnings, Adverse reactions | N7U69T4SZR |
| Olanzapine | OLANZAPINE | Sandoz Inc | 1e9666ef-4271-4834-8496-ccb3125d83db | 2026-02-19 | Boxed warning, Warnings, Adverse reactions | N7U69T4SZR |
| OLANZAPINE | OLANZAPINE | Eugia US LLC | 9c745e2e-89d3-44d4-906e-704705c33310 | 2026-02-17 | Boxed warning, Warnings, Adverse reactions | N7U69T4SZR |
| Olanzapine | OLANZAPINE | Aurobindo Pharma Limited | 636665be-9d7e-443a-8134-e8cc47e6ba24 | 2026-02-10 | Boxed warning, Warnings, Adverse reactions | N7U69T4SZR |
| LYBALVI | OLANZAPINE AND SAMIDORPHAN L-MALATE | Alkermes, Inc. | 32ffddd1-4e2b-45d9-9b36-bb730167ec80 | 2026-01-31 | Boxed warning, Warnings, Adverse reactions | N7U69T4SZR |
| Olanzapine | OLANZAPINE | Coupler LLC | 495efc49-7cdb-4b9e-e063-6394a90a547e | 2026-01-27 | Boxed warning, Warnings, Adverse reactions | N7U69T4SZR |
| Artificial Sweetener Detox 6034 | ARTIFICIAL SWEETENER DETOX | Professional Complementary Health Formulas | 38f2ae0b-2b1f-4b49-934d-fe1556f84d93 | 2026-01-08 | Warnings | Z0H242BBR1 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.